The global pediatric vaccine market involves immunization of children and infants between the ages of birth to 18 years through vaccination to prevent various illnesses. Pediatric vaccines provide protection against 16 vaccine-preventable diseases by boosting the body's immune system to recognize and destroy pathogens like viruses and bacteria. Some of the commonly used pediatric vaccines include polio, measles, rubella, rotavirus, pneumonia, meningococcal disease, chickenpox, and more. They are either live attenuated or inactivated depending on the pathogen. Pediatric vaccination aims to control and eliminate life-threatening diseases during childhood.

Key players operating in the pediatric vaccine market are GlaxoSmithKline Plc., Merck and Co., Inc., Pfizer Inc., Sanofi S.A., Panacea Biotec, Zydus Cadila, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech, and Indian Immunologicals Ltd.

Key Takeaways
Key players related content comprises GlaxoSmithKline Plc., Merck and Co., Inc., and Pfizer Inc. being the top players dominating the global pediatric vaccine market with their wide product portfolio and global presence.

Growing disease burden of diseases like pertussis, pneumonia, rotavirus gastroenteritis, and HPV is expected to drive the Pediatric Vaccines Market Demand significantly during the forecast period. According to WHO estimates, pneumonia killed over 800,000 children under 5 years of age, mainly in developing countries, in 2019.

Technological advancements like development of improved adjuvants, production techniques, and thermostability of vaccines could enhance immunization and enable stockpiling of pediatric vaccines in remote areas. Newer vaccine candidates targeting diseases like dengue, zika, RSV are in the pipeline which will further support market growth.

Market Trends
Combination pediatric vaccines are gaining popularity for allowing simultaneous protection against multiple diseases with a single shot, improving compliance. Key players are focusing on combination products to reduce the number of required injections.

Advent of recombinant DNA technology is assisting in developing improved pediatric vaccines. Newer antigens can be identified recombinantly and included in vaccine formulations for stronger and long lasting immune response.

Get more insights on Pediatric Vaccines Market